Literature DB >> 19747566

Role of Wnt/β-catenin signaling in liver metabolism and cancer.

Satdarshan Pal Singh Monga1.   

Abstract

Wnt/β-catenin signaling is known for its role in embryogenesis as well as carcinogenesis. In the liver, it plays many critical roles during hepatic development and regeneration, and its dysregulation is evident in aberrant hepatic growth during various liver tumors. Its chief cellular roles in the liver include regulation of processes of cell proliferation, apoptosis, oxidative stress and differentiation, which in turn contributes to hepatic growth, zonation, xenobiotic metabolism and other metabolic processes inherent to the liver. Most of these functions of the Wnt/β-catenin signaling are dictated through the highly temporal and tissue-specific or non-specific transcriptional targets of the pathway. In addition, some of the critical functions such as cell-cell adhesion and perhaps maintenance of various junctions that are critical from an epithelial cell biology perspective are also a function of β-catenin, which is the central component of the canonical Wnt pathway. Various animal models and clinical studies have demonstrated the spectra of Wnt/β-catenin signaling in liver health and disease. Thus therapeutic modulation of this pathway for improved hepatic health is inevitable in the future. The current review discusses the advances in our understanding of the Wnt/β-catenin signaling in liver physiology and pathology especially in hepatic metabolism and various tumors in adult liver and goes on to extrapolate the pre-clinical significance and possible translational implications of such findings.
Copyright © 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747566      PMCID: PMC2891959          DOI: 10.1016/j.biocel.2009.09.001

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  106 in total

Review 1.  WNT/beta-catenin signaling in liver health and disease.

Authors:  Michael D Thompson; Satdarshan P S Monga
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

2.  Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Anne Rullier; Gaelle Cubel; Christophe Laurent; Jessica Zucman-Rossi; Charles Balabaud
Journal:  Liver Int       Date:  2008-09-18       Impact factor: 5.828

3.  Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.

Authors:  T L Mao; J S Chu; Y M Jeng; P L Lai; H C Hsu
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

4.  HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.

Authors:  Sandra Rebouissou; Sandrine Imbeaud; Charles Balabaud; Virginie Boulanger; Justine Bertrand-Michel; François Tercé; Charles Auffray; Paulette Bioulac-Sage; Jessica Zucman-Rossi
Journal:  J Biol Chem       Date:  2007-03-22       Impact factor: 5.157

5.  Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.

Authors:  Sharon Amit; Ada Hatzubai; Yaara Birman; Jens S Andersen; Etti Ben-Shushan; Matthias Mann; Yinon Ben-Neriah; Irit Alkalay
Journal:  Genes Dev       Date:  2002-05-01       Impact factor: 11.361

6.  ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.

Authors:  Masakatsu Eguchi; Cu Nguyen; Sung Chan Lee; Michael Kahn
Journal:  Med Chem       Date:  2005-09       Impact factor: 2.745

7.  P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.

Authors:  Ya-Wen Chen; Yung-Ming Jeng; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

8.  Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.

Authors:  Albert Braeuning; Riccardo Sanna; Joerg Huelsken; Michael Schwarz
Journal:  Drug Metab Dispos       Date:  2009-02-23       Impact factor: 3.922

9.  Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.

Authors:  Thomas Decaens; Cécile Godard; Aurélien de Reyniès; David S Rickman; François Tronche; Jean-Pierre Couty; Christine Perret; Sabine Colnot
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.

Authors:  Benjamin Cieply; Gang Zeng; Tracy Proverbs-Singh; David A Geller; Satdarshan P S Monga
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more
  73 in total

1.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.

Authors:  Xu-Feng Zhang; Xinping Tan; Gang Zeng; Amalea Misse; Sucha Singh; Youngsoo Kim; James E Klaunig; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 3.  EpCAM and its potential role in tumor-initiating cells.

Authors:  Sannia Imrich; Matthias Hachmeister; Olivier Gires
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

Review 4.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

5.  β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.

Authors:  Michael D Thompson; Akshata Moghe; Pamela Cornuet; Rebecca Marino; Jianmin Tian; Pengcheng Wang; Xiaochao Ma; Marc Abrams; Joseph Locker; Satdarshan P Monga; Kari Nejak-Bowen
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

6.  Multivariate association analysis with somatic mutation data.

Authors:  Qianchuan He; Yang Liu; Ulrike Peters; Li Hsu
Journal:  Biometrics       Date:  2017-07-19       Impact factor: 2.571

7.  Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice.

Authors:  Argyrios Sklavos; Theofilos Poutahidis; Alexander Giakoustidis; Kali Makedou; Katerina Angelopoulou; Alexander Hardas; Paola Andreani; Argyro Zacharioudaki; George Saridis; Thomas Goulopoulos; Kalliopi Tsarea; Maria Karamperi; Vassilios Papadopoulos; Vassilios Papanikolaou; Apostolos Papalois; Stavros Iliadis; Satvinder Mudan; Daniel Azoulay; Dimitrios Giakoustidis
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

8.  Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.

Authors:  Evan R Delgado; Jing Yang; Juhoon So; Stephanie Leimgruber; Michael Kahn; Tohru Ishitani; Donghun Shin; Gabriela Mustata Wilson; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2014-05-10       Impact factor: 4.307

Review 9.  Wnt modulators in the biotech pipeline.

Authors:  Jean-Philippe Rey; Debra L Ellies
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

10.  Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.

Authors:  Johanna G Miquet; Thomas Freund; Carolina S Martinez; Lorena González; María E Díaz; Giannina P Micucci; Elsa Zotta; Ravneet K Boparai; Andrzej Bartke; Daniel Turyn; Ana I Sotelo
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.